Pfizer Inc. provided earnings guidance for the financial year 2023. For the year, the company expected to reported revenue of $67.0 to $71.0 Billion, the revenues Excluding COVID-19 Products Expected to Grow 7% to 9% Operationally Compared to Full-Year 2022 and Revenue Guidance for Comirnaty of $13.5 Billion and Paxlovid of $8 Billion.